- $135.28m
- $102.15m
- $99.43m
- 97
- 55
- 95
- 96
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 83 | 90.6 | 77.5 | 87.8 | 99.4 |
Cost of Revenue | |||||
Gross Profit | 31.1 | 41.5 | 37.9 | 40.5 | 45.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 88.6 | 87.8 | 74.1 | 87.6 | 97.4 |
Operating Profit | -5.63 | 2.81 | 3.34 | 0.239 | 2.06 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.06 | 3.79 | 3.45 | 0.192 | 2.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.9 | 3.75 | 3.42 | 0.153 | 2.87 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12.9 | 3.75 | 3.42 | 0.153 | 2.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.9 | 3.75 | 3.42 | 0.153 | 2.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.75 | 0.234 | 0.192 | 0.048 | 0.201 |
Dividends per Share |